| Home \ Media \ Media Coverage |
|
Media Coverage
Search for:
in:
Managing Intellectual Property Magazine
Flavour of the Month in Brussels
Date: 30 September 2006
At a recent seminar in Brussels, co-organizd by the Stockholm network, the leading pan-European think tank and market-oriented network, and MIP European SMEs were again on the agenda. More specifically, the topic for discussion was: Do IP rights represent a barrier to innovation or an engine for growth for SMEs?
The issue of IP rights and their usefulness to SMEs is certainly a hot topic in Brussels, and the attendees at the seminar expressed a renage of different views. More interesting, however, was the fact that the SMEs themselves could not agree on one specific model for IP exploitation.  Prospect Magazine
Prospect Think Tank of the Year Awards
Date: 26 September 2006
David Walker said "the past year has been a good one for tankery. We received a number of strong recommendations and the publications field was outstanding." Among tanks commended by the judges were Reform, Centre for Cities, the Stockholm Network, the Work Foundation, the New Local Government Network, the Constitution Unit, the Social Market Foundation and Civitas.
National Review Online
Stethoscope Socialism
Date: 13 September 2006
In America, patients and doctors often make medical decisions and thus demand the best-available diagnostic tools, procedures, and drugs. Affordability obviously plays its part, but the fact that most Americans either pay for themselves or carry various levels of insurance guarantees a market whose profits reward medical innovators.
Under socialized medicine, public officials administer a single budget and usually ration care among a population whose sole choice is to take whatever therapies the state monopoly provides. “In a service that is free at the point of delivery, demand will always tend to outstrip supply,” explains David Smith. In Impatient for Change: European Attitudes to Healthcare Reform, published by the free-market Stockholm Network, he adds: “[R]ationing by waiting times or by the range of treatments on offer has been a regular feat Medicina TV.com
Colesterol: Implicaciones Sociosanitarias y Políticas del un Abordaje Insuficiente (Informe de The Stockholm Network)
Date: 13 September 2006
Following a large cardiovascular conference recently held in Spain, this article discusses the findings of the Stockholm Network's publication: 'Cholesterol: The Public Policy Implications of not Doing Enough',
in regard to Spain's growing cholesterol problem. Article in Spanish Pharmaceutical Executive Europe
Big Pharma Strikes Back
Date: 10 September 2006
Senator Schumer's comments represent an arcane and obsolete view regarding the industry's structure and about the so-called innovative-generic divide. The global pharmaceutical industry as we know it is undergoing some significant changes. Pricing models as well as different forms of exclusivity (not only patents but also other sui generis forms such as data exclusivity) are becoming much more complex. Having experienced some significant difficulties in the past decade, Big Pharma is now starting to internalize and to adapt, sometimes with considerable costs - to the challenges of the future. Generics companies must also do the same, or they will find themselves under increasingly more 'innovative' attacks.
|
Download the full article: Flavour of the Month in Brussels